Impulse Control Problems May Predict Involuntary Movements in Parkinson’s Disease

For millions of people living with Parkinson’s disease, the promise of dopamine replacement therapy comes with an unwelcome paradox. The very medications that restore movement can, over time, trigger two devastating complications that seem to pull in opposite directions: impulse control disorder, in which patients lose the ability to restrain urges around gambling, spending, eating, or sexuality, and levodopa-induced dyskinesia, the involuntary writhing and twitching that emerges after years of treatment. Clinicians have long treated these as separate problems arising from the same drugs. A new study now suggests they are far more intimately connected than anyone suspected, linked through a specific network of cortical brain regions whose vulnerability may determine which patients spiral into dyskinesia.

The research, published in Translational Psychiatry, drew on data from the Parkinson’s Progression Markers Initiative, one of the most extensively characterized longitudinal cohorts in movement disorder research. A team led by Sung-Woo Kim and Min Seok Baek of Yonsei University Wonju College of Medicine, together with colleagues at Korea University, Chung-Ang University, and Yonsei University College of Medicine, followed 464 patients with Parkinson’s disease for more than four years. At the start of the observation window, participants were categorized according to whether they showed signs of impulse control disorder. The researchers then tracked who went on to develop levodopa-induced dyskinesia, using survival analysis to model the timing of that transition while statistically adjusting for age and sex.

The headline result was striking in its clarity. Patients who began the study with impulse control disorder faced a significantly elevated risk of subsequently developing dyskinesia, with a hazard ratio of 1.3375 and a p-value of 0.0238. In practical terms, a history of impaired impulse control increased the hazard of dyskinesia by roughly a third compared with patients who had no such history. Crucially, this association held even after the researchers accounted for putaminal dopamine transporter availability, the standard imaging measure of how much dopamine signaling capacity remains in the striatum, the deep brain structure most directly damaged by Parkinson’s pathology. That independence matters, because it suggests the link between the two complications cannot be explained away by simply saying some patients have more advanced dopamine depletion than others.

To understand why impulse control disorder might foreshadow dyskinesia, the team turned to brain imaging and network neuroscience. Rather than examining isolated regions, they analyzed morphological similarity connectivity, a technique that quantifies how similar two brain areas are in their structural characteristics, such as cortical thickness and surface features, and treats the whole brain as a web of interrelated nodes. Using threshold-free network-based statistics, a method that scans the entire connectome for group differences without imposing arbitrary cutoffs, they identified a subnetwork whose connectivity was reduced in patients with impulse control disorder compared with those without it.

The hubs of this disrupted subnetwork were revealing. They centered on the bilateral paracentral lobules, regions tucked into the medial surface of each hemisphere where the leg and lower body representations of the motor cortex reside, and the left caudal anterior cingulate cortex, a region deeply involved in conflict monitoring, inhibition, and the regulation of motivated behavior. The involvement of the anterior cingulate fits neatly with decades of work implicating frontostriatal circuits in impulse control disorder, where weakened top-down control from prefrontal and cingulate regions fails to restrain striatal drive. The paracentral lobules, by contrast, point toward the motor side of the story, hinting that the same cortical architecture that governs inhibition also shapes how the motor system responds to chronic dopamine stimulation.

The pivotal analytical step came with causal mediation analysis, a statistical framework designed to test whether a measured variable lies on the causal pathway between an exposure and an outcome. The researchers computed the within-module z-score of the left paracentral lobule, a graph-theoretic metric that captures how strongly a node connects to other members of its own network module, essentially measuring that region’s local importance within its community. Their analysis showed that this topological property mediated the association between impulse control disorder-related network disruption and the later development of dyskinesia, with an average causal mediation effect of 0.0136 and a 95 percent confidence interval spanning 0.0028 to 0.0328, an interval that excludes zero and therefore indicates a statistically reliable mediating pathway.

Just as telling was what did not mediate the relationship. Putaminal dopamine transporter availability, the molecular marker most closely tied to Parkinson’s disease progression and dopaminergic treatment burden, showed no such mediating effect. The pathway from impulse control disorder to dyskinesia, in other words, appears to run through the organization of cortical networks rather than through the raw degree of dopamine loss in the striatum. This reframes the problem: two patients with identical dopamine transporter scans may carry very different risks of dyskinesia depending on the integrity of a cortical subnetwork anchored in the paracentral lobules and anterior cingulate cortex.

The mechanistic story that emerges is one of converging vulnerabilities. Both impulse control disorder and levodopa-induced dyskinesia are known consequences of dopaminergic therapy, and both have been linked to dysfunction in the frontostriatal circuits that normally balance reward seeking against behavioral restraint and smooth movement against excessive motor output. The new findings suggest that when impulse control disorder appears, it is not merely an isolated neuropsychiatric side effect but a visible signal that the cortical network supporting inhibitory control has already been reorganized. That reorganization, particularly the altered local connectivity of the left paracentral lobule, may create a topological weak point through which chronic dopamine stimulation later expresses itself as involuntary movement.

For clinicians, the implications are immediate and practical. Impulse control disorder already carries serious consequences for quality of life, social functioning, and decision-making, and it is often underreported because patients may be reluctant to disclose gambling or compulsive behaviors. The study argues that a documented history of impulse control disorder should be treated as a risk marker for dyskinesia and incorporated explicitly into treatment planning. Neurologists weighing how aggressively to titrate levodopa, or considering dopamine agonists and other adjunctive therapies, could use this history to identify patients who warrant closer monitoring, more conservative dosing strategies, or earlier consideration of motor complication mitigation approaches.

The research also opens productive avenues for future work. Morphological similarity connectivity is a structural measure, and linking it to functional network dynamics, longitudinal dopamine imaging, and ultimately prospective validation in independent cohorts will be essential to confirm the causal narrative that mediation analysis implies. Because the analysis relied on de-identified data from the Parkinson’s Progression Markers Initiative, a public-private partnership funded by the Michael J. Fox Foundation for Parkinson’s Research and dozens of industry and philanthropic partners, the findings rest on one of the most rigorously standardized datasets available, but replication across diverse populations remains the necessary next step. Still, the core message is already compelling: in Parkinson’s disease, the brain’s impulse control circuitry and its motor stability are two faces of the same cortical network, and watching one may allow clinicians to protect the other before dyskinesia takes hold.

Subject of Research: The cortical network mechanism linking impulse control disorder to levodopa-induced dyskinesia in Parkinson's disease

Article Title: Impulse control disorder is linked to dyskinesia development through a cortical network in Parkinson’s disease

Article References: Kim, S.-W., Shin, S.-K., Baik, K., Baek, M. S., & Park, M. (2026). Impulse control disorder is linked to dyskinesia development through a cortical network in Parkinson’s disease. Translational Psychiatry. https://doi.org/10.1038/s41398-026-04501-9

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04501-9

Keywords: Parkinson's disease, impulse control disorder, levodopa-induced dyskinesia, cortical network, frontostriatal circuits, paracentral lobule, anterior cingulate cortex, dopamine transporter, morphological similarity connectivity, causal mediation analysis, network neuroscience, PPMI cohort